St. John's wort: natural does not necessarily mean safe
the ONA take:
According to a study published in the journal Clinical and Experimental Pharmacology and Physiology, researchers in Australia have found that adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
"It's concerning to see such severe adverse reactions in our population, when people believe they are doing something proactive for their health with little risk," lead researcher Claire Hoban, of the University of Adelaide, said in a university news release.
The study showed that side effects associated with St. John's wort use included anxiety, dizziness, hypertension, nausea, and panic attacks. The authors of the study that many patients taking St. John's wort may not be aware that they are at risk for certain adverse reactions. Patients should be advised to visit a health care professional for treatment of depression rather than self-treating with natural remedies.
St. John's wort is a popular herbal product used to treat depression in some patients. It is also known to be involved in several drug-drug interactions, particularly with oral contraceptives, anticoagulants, and some anti-cancer drugs.
Adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|